Company intelligence / Profile preview

Intabio

Fremont, California, United States

Ownership: Private
Employees: ~40
Development stage: Other

Overview

Intabio develops and commercializes microchip-based imaging capillary isoelectric focusing–mass spectrometry (icIEF‑MS) platforms such as the Blaze system and, under SCIEX, the Intabio ZT system, enabling high‑throughput characterization of charge variants and post‑translational modifications in intact biotherapeutic proteins to accelerate biologic development and manufacturing.[1][2][3][5]

Modalities: DeviceBiologic
Industry: Non-Drug Biotech

Partnerships

SCIEX (strategic integration and acquisition partner for icIEF‑MS workflows)[1][5]Protein Metrics (Byos software integration for Blaze data analysis)[3]Thermo Fisher Scientific (MS compatibility: Q Exactive Plus)[3]

Beyond the preview

Go deeper on Intabio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intabio.

Explore the full profile